Skip Navigation

About the Center for Chronic Lymphocytic Leukemia

  • The Center for Chronic Lymphocytic Leukemia is part of the Hematologic Oncology (Blood Cancers) Treatment Center at Dana-Farber/Brigham and Women's Cancer Center. The Center promotes a comprehensive approach to the treatment of patients with chronic lymphocytic leukemia (CLL) and provides a centralized hub for CLL research.

    The program also offers access to clinical trials of exciting new drugs, as well as extensive prognostic testing, tissue banking, and stem cell transplantation for CLL.

    Patients may access a comprehensive range of services specialized for CLL treatment, including:

    From the time of diagnosis, Dana-Farber offers a personalized CLL risk-assessment, which provides detailed, patient-specific information about an individual's disease and prognosis. Our CLL-focused physicians then work with patients to use this information in planning and implementing treatment strategies. We offer patients with CLL specialized clinical trials, which give patients the opportunity to receive novel therapies on clinical trials. Our ultimate research goal is to improve current therapies to benefit all patients.

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber/Brigham and Women's Cencer Center logo
    US News adult badge - smaller
  • Matthew Davids, MD, MMSc, on Advances in CLL Treatment
    Matthew Davids, MD, MMSc, of Dana-Farber’s Center for Chronic Lymphocytic Leukemia, shares updates on advances in treating newly-diagnosed and relapsed CLL. New approaches include ibrutinib + FCR for younger, newly-diagnosed patients and a combination of rituximab and venetoclax for relapsed patients.

  • Services and Support at Dana-Farber

    new patient coordinators

    Becoming a Patient

    As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

    patient ratings pie chart

    How Our Blood Cancer Patients Rate Dana-Farber

    Take a look at our patient satisfaction survey results for our patients treated for various blood cancers.
    cover supportive resources brochure

    Support Services and Amenities

    We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

  • leukemia cells

    Rapid Heme Panel: A Major Advance in Blood Cancer Testing

    Physicians at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, critical information to aid the choice of treatment.
    Blum Center creative arts program participant

    The Eleanor and Maxwell Blum Patient and Family Resource Center

    The Blum Resource Center provides patients and family members with a comfortable environment to learn more about disease treatment and management.

    healthy smoothies

    Eating Well During Cancer Video Series

    This video series and resource toolkit features Dana-Farber nutrition specialist Stacy Kennedy, MPH, RD, CSO, LDN, and explores how diet can help support your health and wellbeing during and after cancer treatment.